Shepherd, Finkelman, Miller & Shah, LLP-Attorneys at Law

Violations of federal securities laws as a result of the Company’s issuance of a series of materially false statements. It is alleged that, due to a series of accidents at Hecla’s Lucky Friday mine during 2011, the Mine Safety and Health Administration (“MSHA”) engaged in a close inspection of the mine and, in early December, issued an accident report accusing Hecla of safety failures that led to a miner’s death in April of 2011. Thereafter, on January 5, 2012, MSHA issued a closure order for the Lucky Friday mine for the removal of built-up material in the shaft that had been leaking from a pipe into the shaft for a number of years. On January 11, 2012, Hecla announced the mine would be closed for up to a year based upon MSHA’s order. As a result of the closure, Hecla reduced its estimated silver production for 2012 from more than 9M ounces to around 7M ounces. The Complaint alleges that Defendants knew, but concealed, the following adverse facts, among others: (a) Hecla was not in compliance with safety regulations at its Lucky Friday mine; (b) following the December 2011 closure, Hecla would be unable to reestablish mining operations at the mine by February of 2012, as it had previously represented; (c) the Company improperly accounted for its contingent liabilities, in violation of Generally Accepted Accounting Principles; and (d) based on the foregoing, Defendants lacked a reasonable basis for their positive statements regarding Heckla’s operations and its expected silver production. Filed in D. Id.

Lead Plaintiff Motion Date: The deadline to file for lead plaintiff in this action is 04/02/2012.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.

Violations of federal securities laws as a result of the Company’s issuance of a series of materially false statements. Columbia is an international pharmaceutical company that develops and markets women’s health care and endocrinology products. The Complaint alleges that, throughout the Class Period, Columbia conditioned investors to believe that the Company’s PROCHIEVE progesterone gel 8% (“PROCHIEVE 8%”), a gel intended to prevent pre-term births in women with short cervices, would receive FDA approval through a host of materially false and misleading statements regarding the safety and efficacy of the product, as well as reportedly positive results from PROCHIEVE’s clinical trials. On January 17, 2012, the FDA published information ahead of a meeting by the Advisory Committee for Reproductive Health Drugs of the FDA scheduled for January 20, 2012. The FDA documents revealed that PROCHIEVE 8% did “not support the efficacy of progesterone gel compared with placebo in reducing the risk of preterm births before 33 completed weeks of gestation among women with a short cervical strength.” Moreover, the safety of the gel was similar to a placebo as “[n]o maternal deaths occurred and the rates of fetal, neonatal and infant deaths were similar in both treatment arms.” Filed in D.N.J.

Lead Plaintiff Motion Date: The deadline to file for lead plaintiff in this action is 04/02/2012.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.

Violations of federal securities laws as a result of the Company’s issuance of a series of materially false statements. The Complaint alleges that on December 12, 2011, The New York Times released an article, entitled “Profits and Questions at Online Charter Schools,” which chronicled a myriad of improper practices at K12’s main virtual charter schools, including: (i) high-pressure sales strategies aimed strictly at enrolling students, irrespective of the students’ suitability for online education; (ii) administrative pressure to pass enrolled students, regardless of academic performance; and (iii) overall failure of K12 students to maintain grade-level performance in math and reading. The Complaint alleges that the true facts, known by Defendants but concealed from the investing public during the Class Period, were that the Company: (i) misstated and failed to disclose it had engaged in improper and deceptive recruiting and sales strategies; (ii) misstated and failed to disclose the administrative pressure from upper management levels to pass students despite poor (or nonexistent) academic performance, so as to maintain high enrollment levels and, in turn, receive continued government payments; and (iii) failed to maintain overall math and reading performance levels of its students equal to statewide, grade-level performance. Filed in E.D. Va.

Lead Plaintiff Motion Date: The deadline to file for lead plaintiff in this action is 04/02/2012.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.

Violations of federal securities laws as a result of the Company’s issuance of a series of materially false statements. K-Sea provides marine transportation for refined petroleum products to locations throughout the United States. Throughout the Class Period, K-Sea failed to disclose, among other things, that: (a) it was allowing its customers to renew contracts on very short terms in order to sustain its utilization rates; (b) the lack of a lease renewal option on its Norfolk, VA water treatment facility would require the Company to overpay for the purchase of the facility by $1.7M in order to keep its oily water disposal business; and (c) K-Sea’s debt situation was worse than reported so that a planned equity offering would be insufficient to protect the Company from breaching its financial covenants. On January 28, 2010, before trading commenced, the Company revealed that K-Sea had incurred a $1.7M charge in connection with overpaying for its water treatment facility due to lack of lease renewal options, the Company’s vessel utilization was the lowest in a decade, and K-Sea’s dividend was suspended. As a result of these revelations, K-Sea units plummeted $4.99 or 33.5%, to close at $9.89 on January 28, 2010, on exceptionally heavy trading volume. Filed in D.N.J.

Lead Plaintiff Motion Date: The deadline to file for lead plaintiff in this action is 03/27/2012.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.

Violations of federal securities laws as a result of the Company’s issuance of a series of materially false statements. The Complaint alleges that, throughout the Class Period, Defendants repeatedly touted HMA’s strong financial performance and growth, its increase in hospital admission rates, and its compliance with all applicable laws and regulations. However, on August 3, 2011, Defendants announced that the U.S. Department of Health and Human Services had issued a subpoena requesting “information on [HMA’s] physician referrals as well as ownership and management at our whole-hospital physician joint ventures, among other items.” On this news, shares of HMA common stock fell by $0.80, to close at $7.97 per share. Then, on January 9, 2012, an analyst from CRT Capital Group issued a report stating that HMA’s former compliance director, Paul Meyer, filed a lawsuit against the Company for violation of Florida’s Private Sector Whistleblower’s Act. In addition to being HMA’s Director of Compliance at the time of his termination, Meyer was a 30-year veteran of the FBI, Healthcare Fraud Unit, in Miami. On this news, shares of Health Management dropped another $0.53 per share, falling from $7.49 per share to $6.96. Filed in M.D. Fla.

Lead Plaintiff Motion Date: The deadline to file for lead plaintiff in this action is 03/26/2012.

Join This Action: To apply to join this action and be represented by Shepherd, Finkelman, Miller & Shah LLP, please click here for a certification form to submit your information.

Send Us Information: If you have information about this action that you would like to provide us, please click here.